Article
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma
18 Nov 2020
Abstract excerpt
Malignant pleural mesothelioma (MPM) is an aggressive malignancy of the pleura that is currently incurable due to the lack of an effective early diagnostic method and specific medication. The CDKN2A (p16) and NF2 genes are both frequently mutated in MPM. To understand how these mutations contribute to MPM tumor growth, we generated NF2/p16 double-knockout (DKO) cell clones using human MeT-5A and HOMC-B1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
